Sponsor Pipeline

CytoCares Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 1
2
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07177911 Safety and Efficacy Study of CC312 for Moderate to Severe SLE SLE - Systemic Lupus Erythematosus Recruiting
NCT06037018 Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell… Non-hodgkin Lymphoma Recruiting
Early Phase 1
NCT06888960 Safety Study of CC312 in Autoimmune Disease Patients Systemic Lupus Erythematosus (SLE) Recruiting
NCT07193810 A Study of CC312 for Relapsed/Refractory Autoimmune Diseases SLE - Systemic Lupus Erythematosus Recruiting
Disease Areas
Lupus (SLE) (3) Scleroderma (2) Leukemia (1) Chronic Lymphocytic Leukemia (CLL) (1) Non-Hodgkin Lymphoma (1) Rheumatoid Arthritis (1)
Get alerts when CytoCares Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free